Most Active Stories
- Why rural Missouri is losing doctors
- Would 'Right To Farm' Ballot Question Protect Family Farms Or Ag Corporations?
- Ameren blames EPA standards for coal plant closure, Nixon signs bill to allow less restrictions
- Why the health insurance marketplace could be called a success in Missouri
- MODOT makes revisions to Amendment 7 project list
Tue July 3, 2012
Mo. to get nearly $32 million from drug settlement
Missouri will receive nearly $32 million as its share of a nationwide settlement with British drug maker GlaxoSmithKline.
The company agreed to pay a total of $3 billion for criminal and civil violations involving 10 drugs, including the promotion of antidepressants Paxil and Wellbutrin for unapproved uses.
Attorney General Chris Koster says Missouri's share of the money will go toward its Medicaid health care program for low-income residents. The lawsuit by federal and state governments alleged that GlaxoSmithKline had overcharged the Medicaid program for some drugs.
The settlement is the latest in a string of cases in which lawsuits have alleged pharmaceutical companies marketed drugs for purposes not approved by the U.S. Food and Drug Administration.